High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases

European Journal of Neurology

Volumn 6, Issue 4, 1999, Pages 437-442

  Pelidou, Sigliti Henrietta ^a   Kostulas, Nikolaos ^a   Matusevicius, Darius ^a   Kivisäkk, Pia ^a   Kostulas, Vasilios ^a   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cerebrovascular disease; Cytokines; ELISPOT; IL 10; IL 4

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; MYELIN BASIC PROTEIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CELL SECRETION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0032779717     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.640437.x     Document Type: Article

References (40)

1. Adams DH, Lloyd AR (1997). Chemokines: leukocyte recruitment and activation cytokines. Lancet 349:490-495.
2. Beamer NB, Coul BM, Clark WM, Hazel JS, Silberger JR (1995). Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 37:800-804.
3. Bonita R (1992). Epidemiology of stroke. Lancet 339:342-344.
4. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A, Paul WE (1986). B-cell stimulatory factor 1 enhances the IgE response to lipopolysaccharide-activated B cells. J Immunol 136:4538-4541.
5. Czerkinsky C, Andersson G, Ekre H, Nilsson L, Klareskog L, Ouchterlony Ö (1988). Reverse ELISPOT assay for clinical analysis of cytokine production. 1. Enumeration of gamma-interferon secreting cells. J Immunol Meth 110:29-36.
6. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991). Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220.
7. Deibler GE, Martensson RE, Kies MV (1972). Large scale preparation of myelin basic protein from central nervous tissue of several animal species. Preparative Biochem 2:139-165.
8. Elkarim R, Mustafa M, Kivisäkk P, Link H, Bakhiet M (1998). Cytokine autoantibodies in multiple sclerosis, aseptic meningitis and stroke. Eur J Clin Invest 28:295-299.
9. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M (1994). Pro-inflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 122:135-139.
10. Fiorentino DF, Bond MW, Mosman TR (1989). Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081-2085.
11. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991). IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822.
12. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ (1995). Comparison of suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology 84:536-542.
13. Howard M, O'Garra A (1992). Biological properties of interleukin 10. Immunol Today 13:198-200.
14. Howard M, Farrar J, Hilfiker M, Jonson B, Takatsu K, Hamaoka T, Paul WE (1982). Identification of a T cell derived B cell growth factor distinct from interleukin 2. J Exp Med 155:914-923.
15. + suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur J Immunol 22:1757-1763.
16. Kim JS (1996). Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 137:69-78.
17. Kochanek PM, Hallenbeek JM (1992), Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23:1367-1379.
18. Kostulas N, Kivisäkk P, Huang Y, Matusevicius D, Kostulas V, Link H (1998). Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke 29:462-466.
19. Kucharzik T, Lugering N, Weigelt H, Adolf M, Domschke W, Stoll R (1996). Immunoregulatory properties of interleukin-13 in patients with inflammatory bowel disease. Comparison with interleukin-4 and interleukin-10. Clin Exp Immunol 104:483-490.
20. Lieberman AP, Pitha PM, Shin HS, Shin MI. (1989). Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proceedings of the National Academy of Sciences of the USA 86:6348-6352.
21. Link H (1997). B cells and autoimmunity. In: Molecular biology of multiple sclerosis. Russell WC (editor). Chichester: Wiley, pp. 161-190.
22. Link H, Baig S, Olsson O, Yu-Ping J, Höjeberg B, Olsson T (1990). Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid. J Neuroimmunol 28:237-248.
23. Miller DJ, Njenga MK, Parisi JE, Rodriguez M (1996). Multi-organ reactivity of a monoclonal natural autoantibody that promotes remyelination in a mouse model of multiple sclerosis. J Histochem Cytochem 44:1005-1011.
24. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993). Interleukin-10. Annu Rev Immunol 11:165-190.
25. Olsson T, Wang W-Z, Höjeberg B, Kostulas V, Jiang Y-P, Andersson G, et al. (1990). Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J Clin Invest 86:981-985.
26. Paul WE, Seder RA (1994). Lymphocyte responses and cytokines. Cell 76:241-251.
27. Pennline BJ, Roque-Gaffney E, Monahan M (1994). Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 71:169-175.
28. Powrie F, Coffman L (1993). Cytokine regulation of T cell function: potential for therapeutic intervention. Immunol Today 14:270-274.
29. Righi M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani AD, et al. (1989). Monokine production by microglial cell clones. Eur J Immunol 19:1443-1448.
30. Rodriguez M, Miller DJ, Lennon VA (1996). Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology 46:538-545.
31. Roström B, Link H (1981). Oligoclonal immunoglobulins in cerebrospinal fluid in acute cerebrovascular disease. Neurology 31:590-596.
32. Sörnäs R, Östlund H, Muller R (1972). Cerebrospinal fluid cytology after stroke. Arch Neurol 26:489-501.
33. Spits H, de Vries JE (1992). Interleukin-10. Current Opinion Immunol 4:314-320.
34. Szaflaski J, Burtum D, Silverstein FS (1995). Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 26:1093-1100.
35. Tarkowski E, Naver H, Wallin G, Blomstrand C, Tarkowski A (1995). Altered T-lymphocyte responses in patients with stroke: effect of sympathetic dysfunction? Stroke 26:57-62.
36. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A (1997). Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 110:492-499.
37. Tomimoto H, Akiguchi I, Wakita H, Kinoshita A, Ikemoto A, Nakamura S, Kimura J (1996). Glial expression of cytokines in the brains of cerebrovascular disease patients. Acta Neuropathol 92:281-287.
38. Wang WZ, Olsson T, Kostulas V, Höjeberg B, Ekre HP, Link H (1992). Myelin antigen reactive T cells in cerebrovascular diseases. Clin Exp Immunol 88:157-162.
39. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr (1996). Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 184:2271-2278.
40. Xiao BG, Linington C, Link H (1991). Antibodies to myelinoligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 31:91-96.